Sign In
Buy GH
$127.03
-3.14 (-2.41%)
At Close: Jun 03, 2026
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 1)
Adaptimmune Therapeutics PLC...
Guardant Health Announces Proposed Public Offering of Common Stock
08:37pm, Monday, 01'st Jun 2020
In addition, Guardant Health and SoftBank Investment Advisers expect to grant the underwriter a 30-day option to purchase up to 1,500,000 additional shares of common stock (450,000 additional shares f
Guardant Health to Participate in the William Blair 2020 Growth Stock Conference
08:03pm, Friday, 29'th May 2020
REDWOOD CITY, Calif., May 29, 2020 -- Guardant Health, Inc. (Nasdaq: GH) today announced the company will be participating in the upcoming William Blair Virtual Growth Stock.
Guardant Health: A Rising Star (NASDAQ:GH)
08:55am, Thursday, 28'th May 2020
Guardant Health is a mid-cap company that uses blood biopsies to detect cancer. With the increased focus on healthcare this company has a great future. The pote
Guardant Health: Strong Momentum And Enormous Opportunities (NASDAQ:GH)
08:03am, Sunday, 24'th May 2020
Guardant Health is growing at an impressive speed in a challenging environment. Profit margins are improving and the company has a solid balance sheet to withst
Investing $5,000 in These 3 Stocks Could Make You a Fortune Over the Next 10 Years
11:45am, Saturday, 23'rd May 2020
There are a few fantastic growth stocks that you can buy right now that have a good shot at making you a lot of money relatively quickly. David Gardner, co-founder of The Motley Fool, thinks that inv
UAB Professor Co-Authors Study On Sex-Based Differences In Autoimmune Disease Susceptibility
08:50pm, Monday, 18'th May 2020
The study says gene variants cause men and women to have different vulnerabilities to lupus and Sjögren's syndrome.
REDWOOD CITY, Calif., May 15, 2020 -- Guardant Health, Inc. (Nasdaq: GH) along with leading academic institutions and pharmaceutical companies will present data highlighting.
Guardant Health: Long-Term Catalysts Outweigh The Near-Term Headwinds
08:11am, Wednesday, 13'th May 2020
The COVID-19 pandemic has shrunk Guardant’s test volumes, disrupting its nearly two-year-long growth momentum. After more than doubling in value last year, the
Guardant Health Inc (GH) Q1 2020 Earnings Call Transcript
09:01pm, Saturday, 09'th May 2020
Ladies and gentlemen, thank you for standing by, and welcome to the Guardant Health Q1 2020 Earnings Call. Earlier today, Guardant Health released financial results for the quarter ended March 31, 20
Adaptive Biotechnologies: A Coronavirus Battle Deserving A Premium Valuation
11:33am, Saturday, 09'th May 2020
Adaptive has partnered with industry giants to battle the COVID-19 infection with a dual-pronged approach. The milestone payments could offset any pandemic-rela
Guardant Briefly Tops Buy Point; Pulled 2020 Outlook Is Now 'Achievable'
08:27pm, Friday, 08'th May 2020
Guardant Health posted a strong first-quarter beat, sending Guardant Health stock briefly into breakout territory Friday even after the diagnostics company pulled its 2020 outlook.
Will Guardant Health Continue to Surge Higher?
02:27pm, Friday, 08'th May 2020
As of late, it has definitely been a great time to be an investor Guardant Health
U.S. RESEARCH ROUNDUP-Becton Dickinson, Epam Systems, PayPal Holdings
11:36am, Friday, 08'th May 2020
Wall Street securities analysts on Friday revised their ratings and price targets on several
U.S.-listed companies, including Becton Dickinson, Epam Systems and PayPal Holdings.
HIGHLIGHTS
Guardant Health, Inc. (GH) CEO Helmy Eltoukhy on Q1 2020 - Earnings Call Transcript
03:59am, Friday, 08'th May 2020
Guardant Health, Inc. (NASDAQ:GH) Q1 2020 Earnings Conference Call May 07, 2020, 05:00 PM ET Company Participants Carrie Mendivil - IR Helmy Eltoukhy - Co-Found
